Boston-based Activ Surgical designed ActivSight to provide enhanced visualization and real-time on-demand surgical insights in the operating room. The easy-to-adapt model seamlessly attaches to laparoscopic and robotic systems. It also integrates with standard monitors.
Activ Surgical received CE mark approval for ActivSight in December 2022. The FDA cleared the technology in April 2021.
The company aims to transform the surgical experience using emerging technologies and data. It wants every surgical imaging system to deliver intelligent information, reducing surgical complication rates.About the first AI-enabled ActivSight Intelligent Light case for Activ Surgical
On Dec. 22, 2022, Dr. Matthew Kalady of The Ohio State University Wexner Medical Center used it in a laparoscopic left colectom…